<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158088">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01933893</url>
  </required_header>
  <id_info>
    <org_study_id>139/13</org_study_id>
    <nct_id>NCT01933893</nct_id>
  </id_info>
  <brief_title>Follicular Versus Luteal Pipelle in Repeated Implantation Failure Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pipelle was found to increase pregnancy and implantation rates in women undergoing IVF
      treatment in general, and in particular in repeated implantation failure (RIF). However,
      there is virtually no data regarding the optimal timing for the pipelle.

      The current study aims to compare between follicular and luteal pipelle on pregnancy rate in
      RIF patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>April, 2014</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Repeated Implantation Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Women diagnosed with repeated implantation failure (RIF) who are undergoing IVF treatment.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women diagnosed with RIF who are going to start a new IVF treatment

        Exclusion Criteria:

        Known hydrosalpinx body mass index (BMI) &gt;29 kg/m2 or &lt;18 kg/m2 Low ovarian response
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ido Ben-Ami, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf Harofeh Medical Center, Zerifin, Israel</affiliation>
  </overall_official>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 29, 2013</lastchanged_date>
  <firstreceived_date>August 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pipelle, luteal, follicular, implantation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
